BDH Industries Limited
BSE: BDH.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Jayashree G. Nair
- Employees
- 117
- Headquarters
- Mumbai, India
- IPO year
- 2002
- Market cap
- ₹2.1B
- Website
- http://www.bdhind.com
Loading BDH…
Loading profile data…Frequently asked questions about BDH
What does BDH Industries Limited (BDH.BO) do?
BDH Industries Ltd. engages in the manufacturing of therapeutic formulations. It products include, fentanyl citrate injection usp, acetaminophen oral solution usp, paracetamol tablets, paracetamol injection, benzyl benzoate application, praziquantel, mebendazole, thioridazine oral solution, thioridazine tablets and haloperidol injection. The com...
Where does BDH.BO trade?
BDH Industries Limited (BDH.BO) trades on the Bombay Stock Exchange.
What sector is BDH.BO in?
BDH Industries Limited (BDH.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of BDH Industries Limited?
Jayashree G. Nair is the chief executive officer of BDH Industries Limited (BDH.BO).
Where is BDH Industries Limited headquartered?
BDH Industries Limited is headquartered in India.
Does BDH.BO pay a dividend?
Yes — BDH Industries Limited (BDH.BO) paid a trailing twelve-month dividend of INR 4.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BDH.BO go public?
BDH Industries Limited (BDH.BO) completed its initial public offering in 2002.